GL1X · GenesisL1 explorer

MolNFT v1 · #120236 · protein

The agonist-free structure of human ppargamma ligand binding domain in the presence of the src-1 coactivator peptide

5GTP · Peroxisome proliferator-activated receptor gamma: “The agonist-free structure of human ppargamma ligand binding domain in the presence of the src-1 coactivator…”. X-ray diffraction, 1 ligand (MYR), 1 pocket (best druggability 0.82).…

PDB
5GTP
Type
protein
Length
272 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; Nuclear receptor coactivator 1
UniProt
P37231
Ligands
MYR
Pockets
1 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26167% helix, 5% strandP37231
BNuclear receptor coactivator 1protein1173% helix, 0% strand—

Ligands and binding sites

  • MYR · Myristic acid · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14330.820.8950MYR, GOL

Interfaces

1 interface between chains.

  • A–B · 665 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 5GTP · The agonist-free structure of human PPARgamma ligand binding domain in the presence of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.